author-photo

Kana Miyazaki

Mie University

58

Papers

1272

Citations

Citation Trend

Filter By

Papers (44) Sort By

Journal Conference Others

A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (2)
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (0)
Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation.

2021 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
Long-term follow-up results of a phase II study of dose-adjusted (DA)-EPOCH-R with high-dose methotrexate (HD-MTX) for newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy

2020 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (3)
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (18)
Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data.

2020 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (3)
Gene mutations and sites of involvement in duodenal-type follicular lymphoma

2019
- Kana Miyazaki
Show All
- Source
- Cite
- Save
Citations (0)
Gene Polymorphisms and Vincristine-Induced Neuropathy in Patients Who Received R-CHOP Chemotherapy

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
LONG-TERM FOLLOW-UP OF JCOG0406 STUDY: INTENSIVE IMMUNOCHEMOTHERAPY (R-HIGH CHOP/CHASER) FOLLOWED BY HIGH-DOSE CHEMOTHERAPY (LEED) WITH AUTO-PBSCT IN UNTREATED MANTLE CELL LYMPHOMA: PS1259

2019
Show All
- Source
- Cite
- Save
Citations (0)